After a hospitality-style makeover, 125 High Street secured nearly 150,000 square feet in renewals and expansions. The moves pushed occupancy to about 82%.

Longtime Mattapan homeowners say months of blasting, gas‑safety concerns and parking fears have accompanied construction of a 41‑unit affordable complex at Blue Hill Avenue. Residents want better monitoring and more say.

Chelmsford will demolish two aging fire stations to build modern replacements focused on firefighter health and response coverage. Demolitions begin now with completion aimed for fall 2027.

A Colliers assessment and city briefings found widespread deferred maintenance at five Lowell firehouses, and councilors are weighing roughly $7 million to stabilize the stations.

Construction firms toured Brockton High as the district advances a feasibility study that could lead to a multi‑hundred‑million‑dollar rebuild. The walkthrough and active bid notices show the project is moving toward contractor selection.

Collegium Pharmaceutical is moving its headquarters from Stoughton to One Lincoln in Boston, taking roughly 40,000 sq ft across two floors and becoming the tower’s first biotech tenant.

Skip Sack reached about a $1.1M settlement with Harvard over the failed En Boca in Harvard Square. The deal closes a years‑long fight about construction, a street closure and lost business.

Boston Children’s sold its Peabody outpatient campus for roughly $62 million and will remain a tenant under a lease‑buyback. The move mirrors a wider trend of health systems monetizing property.

A Newton developer wants to convert the brick office block at 7–9 Galen St. into 285 apartments while preserving the historic facade and adding retail and pedestrian space.

After a June sale of the Gordon Building, roughly two dozen Allston shops face steep rent hikes, abrupt parking fees and looming closures. Longtime owners say they can’t absorb the new terms.

Equus Capital Partners bought Centech Park North, a 300,075-SF, two-building industrial campus in Shrewsbury, in a roughly $75M deal. The property is fully leased to life-science and manufacturing tenants.

Synergy bought the 21‑story tower at 265 Franklin Street for $116M, signaling investor appetite for repositioning downtown office stock amid high vacancy.

Exosens is shifting its U.S. base to Sturbridge and adding a second factory to make image-intensifier tubes as demand and big contracts accelerate. The move builds on a small Sturbridge workforce and a planned 2027 production start.